Form 4: BioMarin Pharmaceutical Inc. Executive Erin Burkhart Reports Stock Disposal
SEC Form 4 Filing
Erin Burkhart, GVP, Chief Accounting Officer of BioMarin Pharmaceutical Inc., reports disposing of 993 shares of common stock to cover tax obligations.
Summary
- On May 17, 2024, Erin Burkhart, the GVP, Chief Accounting Officer of BioMarin Pharmaceutical Inc., disposed of 993 shares of common stock.
- The transaction was executed at a price of $76.97 per share.
- Following the transaction, Burkhart directly owns 15,163 shares of BioMarin common stock.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock disposal for tax purposes, and doesn't necessarily indicate a positive or negative sentiment towards the company's prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. This allows investors to track the buying and selling activity of executives and directors, which can provide insights into their perspectives on the company's performance and future prospects.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a small percentage of the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 05/17/2024 | Date of transaction: Disposal of common stock |
| 05/20/2024 | Date of signature for the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.